Relatively little is known about the developmental signals that specify the types and numbers of pancreatic cells. Previous studies suggested that Notch signaling in the pancreas inhibits differentiation and promotes the maintenance of progenitor cells, but it remains unclear whether Notch also controls cell fate choices as it does in other tissues. To study the impact of Notch in progenitors of the b cell lineage, we generated mice that express Cre-recombinase under control of the Pax4 promoter. Lineage analysis of Pax4 + cells demonstrates they are specified endocrine progenitors that contribute equally to four islet cell fates, contrary to expectations raised by the dispensable role of Pax4 in the specification of the a and PP subtypes. In addition, we show that activation of Notch in Pax4 + progenitors inhibits their differentiation into a and b endocrine cells and shunts them instead toward a duct fate. These observations reveal an unappreciated degree of developmental plasticity among early endocrine progenitors and raise the possibility that a bipotent duct-endocrine progenitor exists during development. Furthermore, the redirection of Pax4 + cells from a and b endocrine fates toward a duct cell type suggests a positive role for Notch signaling in duct specification and is consistent with the more widely defined role for Notch in cell fate determination.
Introduction
It is becoming clear that a detailed understanding of normal pancreatic development will be critical for the treatment of pancreatic diseases. Specifically, the directed differentiation of b cells in vitro for cell therapy purposes and the identification of processes that contribute to pancreatic cancers require more information about how pancreatic progenitors choose their cell fates during development. Two outstanding questions about the generation of cell fate diversity in the pancreas are the identity of the signals that promote the differentiation of mature cell fates and the nature of the progenitors that respond to those signals.
During embryogenesis, the pancreatic epithelium proliferates, branches and differentiates to produce three tissue types: exocrine cells that secrete digestive enzymes, ducts that form conduits to the duodenum, and endocrine cells that cluster to form the islets of Langerhans and release hormones into the bloodstream. Endocrine subtypes, including a, b, d, and PP cells, differentiate sequentially and produce the hormones glucagon, insulin, somatostatin, and pancreatic polypeptide, respectively. Although little is known about the mechanisms that specify these cell fates, it has recently become possible to address this question using the Cre-loxP system in transgenic mice. Driver lines that express Cre-recombinase under different pancreatic promoters can be crossed to Cre-activated reporter and responder lines to characterize the fate and the potential of defined populations of progenitors (Branda and Dymecki, 2004) . Notch signaling regulates the development of many tissues by controlling the time at which progenitors differentiate and by influencing their cell fate choices in a manner that is highly dependent on cell context (for reviews see Artavanis-Tsakonas et al., 1999; Raible and Eisen, 1995) . Early in foregut development, Notch signaling in the endoderm has been shown to regulate Ptfla expression and define the normal boundaries of the pancreatic domain (Fukuda et al., 2006) . Later, in the early pancreatic epithelium, Notch signaling is thought to promote the maintenance of a progenitor population at the expense of both exocrine and endocrine differentiation. Loss of Notch signaling in the pancreas of mouse and zebrafish embryos results in stunted growth and the precocious differentiation of either endocrine or exocrine cells (Apelqvist et al., 1999; Esni et al., 2004; Fujikura et al., 2006; Hald et al., 2003; Jensen et al., 2000; Lorent et al., 2004; Yee et al., 2005) . Conversely, expression of the constitutively active intracellular domain, Notch-IC, traps pancreatic progenitors in an undifferentiated state and prevents the formation of endocrine and exocrine tissue (Esni et al., 2004; Lee et al., 2003; Lorent et al., 2004; Murtaugh et al., 2003) . The fate of such Notch-expressing cells is to form tubules that express the early pancreatic marker, Pdx1. During normal development then, Notch signaling must be carefully regulated to balance the expansion of a progenitor pool with differentiation of mature cell types.
In many tissues, Notch regulates cell fate choices as well as the timing of differentiation. In the pancreas, it is possible that Notch signaling plays a positive role in duct specification since duct markers are lost from the early pancreas of zebrafish Notch mutants (Lorent et al., 2004; Yee et al., 2005) . However, inactivation of Notch signaling in the early mouse pancreas by deletion of a floxed RBP-J K allele using the Pdx1-Cre driver line appears to cause the formation of cystic tubules that express duct markers (Fujikura et al., 2006) . This study suggests that, at the very least, Notch signaling is not required for duct differentiation. Although, no gain-of-function analyses support the hypothesis that Notch promotes the duct fate in the pancreas, the expression of Notch-IC in the embryonic zebrafish liver induces ectopic biliary ducts (Lorent et al., 2004) , and the components of the Notch signaling pathway remain highly expressed in pancreatic epithelial tubules from which the ducts are likely to arise (Apelqvist et al., 1999; Lammert et al., 2000) . In addition, the duct-like structures that form in malignancies such as pancreatic ductal adenocarcinoma exhibit high levels of Notch signaling (Miyamoto et al., 2003) and are of great interest in terms of their relationship to normal developmental processes.
Although Notch signaling inhibits the differentiation of early pancreatic progenitors, it is less clear what its effects may be on progenitors of intermediate maturity. In the mouse, it has been difficult to fully characterize the effect of Notch signaling in defined pancreatic progenitors due to lack of appropriate cell-specific driver lines. The expression of Notch-IC in Ngn3 + endocrine progenitors has been shown to inhibit their differentiation (Murtaugh et al., 2003) , but the ultimate fate of these cells could not be analyzed due to embryonic lethality, presumably due to Notch misexpression in the Ngn3 + domain outside of the pancreas. By contrast, expression of Notch-IC in fully differentiated insulin + cells has no demonstrable effect, indicating that Notch function in the pancreas does indeed depend on cell context (Murtaugh et al., 2003) .
One population of pancreatic cells that offer an important target for lineage analysis are progenitors that express the paired domain transcription factor, Pax4. Like Ngn3, Pax4 is transiently expressed in endocrine progenitors during pancreatic development and is downregulated shortly after birth. However, the expression of Pax4 is thought to be downstream of Ngn3, since Pax4 expression is lost in Ngn3 null mutants but not vice versa (Gradwohl et al., 2000; Wang et al., 2004) . Pax4 + cells are found in the undifferentiated pancreatic epithelium, which also contains undifferentiated duct and exocrine progenitors, and eventually delaminate and express hormones. Unlike Ngn3, which is widely expressed in the intestine and nervous system (Jenny et al., 2002; Lee et al., 2003) , Pax4 expression is largely restricted to the pancreas and duodenum making it a better candidate for driving ectopic expression in embryos (Larsson et al., 1998; Sosa-Pineda et al., 1997) . In addition, the fate of Pax4 + cells in normal development represents an interesting focus of inquiry since Pax4 has been implicated in acquisition of endocrine subtype identity. In the absence of Pax4, b and d cells fail to develop and more a cells are observed (Collombat et al., 2003 (Collombat et al., , 2005 Sosa-Pineda et al., 1997) . This reciprocal effect on subtype differentiation suggests that Pax4 may normally function to bias endocrine progenitors away from the a fate toward b/d fates.
To determine the fate of Pax4 + progenitor cells under conditions of normal development and after expression of Notch-IC, we generated transgenic mice that express Cre-recombinase under control of the Pax4 promoter. By lineage tracing with a heritable Cre-activated reporter, we find that Pax4 + cells are specified endocrine progenitors that contribute equally to each of four endocrine subtypes during normal development. As a population then, Pax4 + cells are not biased toward a particular subtype fate, even though the knockout phenotype suggested that they would preferentially adopt b/d fates. Nonetheless, when Pax4 + progenitors are forced to express activated Notch, some are shunted away from a and b fates and instead contribute to ducts. Thus, Pax4
+ cells have both a broader fate and a wider developmental potential than previously appreciated. Moreover, the ability of Notch to promote differentiation of the mature duct fate is unprecedented in the pancreas. It is, however, similar to the classically defined role for Notch in the choice between ''primary'' and ''secondary'' fates and the glial promoting effects of Notch in the nervous system (for reviews see Artavanis-Tsakonas et al., 1999; Raible and Eisen, 1995) .
Results

Pax4
+ cells are specified endocrine progenitors
To determine the contribution of embryonic Pax4 + cells to mature or fully differentiated pancreatic cell fates, we generated transgenic mice, Pax4$Cre, that express Cre-recombinase under the control of the Pax4 promoter. A 4.75-kb fragment upstream from the start of Pax4 transcription was isolated by high-fidelity PCR from mouse genomic DNA and used to drive expression of the transgene (Fig. 1A , see also Section 4). This fragment includes a 0.9-kb regulatory element previously shown to drive pancreatic expression (Brink et al., 2001) . Three independent transgenic lines were generated that showed Cre-mediated expression of human placental alkaline phosphatase (HPAP) when crossed with Z/AP reporter mice. In all three lines, HPAP expression in Pax4$Cre; Z/AP mice was observed only in islets, not in exocrine tissue or in ducts (Fig. 1B) . This observation supports the idea that Pax4 + cells are specified endocrine progenitors.
To employ the Pax4-Cre transgenic line for lineage studies, it is important to confirm by co-localization that Cre activity or expression is restricted to Pax4 + cells during embryogenesis. Unfortunately, no good antibodies to the Pax4 protein are currently available for fluorescent immunohistochemistry, and the Pax4 in situ signal is too weak to support fluorescent in situ detection of mRNA. In addition, we could not detect Cre-recombinase in Pax4-Cre transgenic embryos using available antibodies, likely due to the level of expression.
Therefore, we addressed the problem of co-localization by comparing the expression of a Cre-mediated reporter to the expression of b-galactosidase (b-gal) in mice that had LacZ knocked into the Pax4 locus (Pax4 LacZ ) (SosaPineda et al., 1997) . Embryos carrying the Pax4-Cre transgene, the R26R YFP Cre-dependent fluorescent reporter (Srinivas et al., 2001) , and the Pax4
LacZ knock-in allele were analyzed at E14.5. At this time point, which is near the peak of Pax4 expression, b-gal expression can be clearly detected by fluorescent antibody staining (Fig. 1C) . Similarly, YFP, which marks both progenitors that express Cre-recombinase and their progeny, can be seen in the pancreata of these embryos, albeit in fewer cells (Fig. 1D ). The majority of YFP + cells coexpress b-gal (Fig. 1E , arrowheads), indicating that the transgene is indeed expressed within the Pax4 domain. Although we do see a few YFP + cells that do not obviously express b-gal at this time point, this is understandable given the permanent nature of the YFP label and the transient nature b-gal expression. We assume that b-gal has been downregulated in these cells, though variable antibody staining for b-gal at earlier time points has precluded a direct test of this hypothesis. Less importantly, many of the b-gal + cells do not express YFP, reflecting the mosaic expression of Cre or activation of the reporter. This is consistent with the observation that only 35% of the islet cells in the Pax4$Cre; Z/AP mice are labeled in the adult. Similar observations were made with embryos from Rosa Notch responder mice which also carry a fluorescent reporter (data not shown). Therefore, the co-localization data taken together with the islet-specific fate of Cre-expressing cells provide strong evidence that Cre-recombinase is expressed in a subset of Pax4 + cells in Pax4-Cre transgenic mice.
Pax4 + progenitor cells contribute equally to all islet fates
A careful lineage analysis was performed using the Pax4$Cre transgenic driver line and Z/AP reporter mice to determine the percent contribution of Pax4 + progenitors to different subtypes of endocrine cells in adult islets. Coexpression of HPAP and each of four islet hormones, glucagon ( Fig. 2A and B) , insulin ( Fig. 2C and D) , somatostatin ( Fig. 2E and F) , and PP ( Fig. 2G and H) , was assayed by immunofluorescence. In adult mice, we observed HPAP + cells that coexpressed each type of islet hormone (Fig. 2B , D, F, and H; arrowheads).
To determine whether Pax4 + cells are biased to generate particular endocrine fates, as would be expected from the Pax4 null mice (Sosa-Pineda et al., 1997) , two types of analyses were performed. First, the distribution of endocrine subtypes within the lineage-labeled HPAP + population was compared to the distribution of subtypes that normally occur within islets. If the labeled progenitors are biased toward particular fates, the subtype composition of the HPAP + population should be different from the subtype composition of islets as a whole; if the labeled progenitors are not biased toward particular fates, the subtype composition of the HPAP + population should instead resemble that of the islet. Specifically, the percentage of HPAP + cells that expressed each hormone was compared to the percentage of islet cells that expressed each hormone (5-8 islets randomly selected from sectioned pancreas tissue were counted per hormone per mouse, n = 3 mice). Using this method of analysis, we observed that the distribution of cell types within the HPAP-labeled population did not differ from the distribution of cell types within islets as a whole (Fig. 2I) . Second, if the labeled progenitors are biased toward particular fates, one would expect the HPAP label to be concentrated in some subtypes and less prevalent in others. Therefore, we compared the labeling efficiency of each endocrine subtype, i.e., the percentage of cells of each endocrine subtype that coexpress HPAP. Using this type of analysis, we found that all endocrine subtypes were labeled with the same frequency, about 35% (Fig. 2J , n = 4 mice). These analyses indicate that Pax4 + progenitors contribute equally to all endocrine cell types in the islet. Thus, expression of Pax4 in an endocrine progenitor is not strictly sufficient to assign subtype fate.
Notch signaling biases endocrine progenitors away from a and b fates toward a duct fate
Notch signaling is known to inhibit the differentiation of progenitor cells in the developing pancreas. To determine its effect in the specific context of Pax4 + cells, we used Cre-sensitive Rosa Notch responder mice in combination with the Pax4$Cre driver line. Rosa Notch mice express the constitutively active intracellular domain of Notch1 (Notch-IC) and nuclear-localized EGFP (nEGFP) from the Rosa locus only after deletion of a loxP-flanked stop sequence (Fig. 3A) (Murtaugh et al., 2003) . The fate of cells expressing Notch-IC from the Rosa Notch transgene can be followed by analyzing the heritable expression of nEGFP.
Mice expressing both Pax4$Cre and Rosa Notch transgenes are viable through adulthood and have no gross pancreatic defects. However, upon histochemical staining with the lectin DBA, we observed an increase in duct structures compared to non-transgenic littermates (n = 3 pairs of littermates, Fig. 3B and C) . To more directly analyze this phenotype, we examined the ducts to determine if they contained Notch-expressing cells. Indeed we found that many duct structures contained nEGFP + cells, i.e., Notch-IC expressing cells that are derived from the Pax4 + lineage. Duct structures that contain nEGFP + cells have a range of morphologies and include both large, medium, and small ducts. In 2 week old animals, nEGFP + cells are found in DBA + epithelial tubules that are often in close proximity to islets (Fig. 3G-I ). In older animals ($2 months), however, the tubules have resolved into a few large ducts ( Fig. 3D and F) and many smaller ductules (Fig. 3E ) more reminiscent of normal duct morphology. In larger ducts, nEGFP + cells could be found (Fig. 3D , solid arrowheads) scattered individually among or in groups contiguous with areas of nEGFP À cells (Fig. 3D, arrows) . nEGFP + cells were also observed in the small intercalated ducts within this tissue ( Fig. 3D and E, open arrowheads). Such nEGFP + cells coexpressed the duct markers DBA, Muc1, and CK19 ( Fig. 3D-F) .
To examine whether these cells might represent undifferentiated endocrine progenitors that became ''stuck'' in the ducts, we stained the pancreata of 2-week old Pax4$Cre; Rosa Notch ; Pax4 LacZ/+ mice for a panel of endocrine progenitor markers. nEGFP + /DBA + cells did not express Pdx1 (Fig. 3G) , Pax6 (Fig. 3H) Not all endocrine progenitors that express Notch-IC contribute to ducts. Expression of nEGFP can also be observed in mature islet cell types (Fig. 4A-H , arrowheads), indicating that expression of Notch-IC is not completely incompatible with endocrine differentiation (It is important to note that these cells do not express DBA.). However, unlike the expression of HPAP in Pax4$Cre; Z/AP mice, the pattern of nEGFP expression in Pax4$Cre; Rosa Notch mice is not evenly distributed among all fates in the islet. At first glance, nEGFP + cells tend to be located near the perimeter of the islet rather than in the center (Fig. 4A, C, E, and G) , suggesting a decreased labeling efficiency among b cells. Indeed, counterstaining for islet hormones reveals that a and b fates are least efficiently labeled by nEGFP among the four islet fates in Pax4$Cre; Rosa Notch mice (Fig. 4I , n = 3 mice. a = 16.9 ± 2.8%; b = 23.4 ± 3.1%; d = 43.7 ± 4.3%; PP = 61.0 ± 9.7%). That the labeling efficiency of d and PP cells in Rosa Notch mice is greater than that observed during lineage tracing with the Z/AP line ($35%) perhaps suggests a higher efficiency of recombination at the Rosa26 locus. Regardless, these data suggest that a and b progenitors are more sensitive to Notch signaling than are d and PP progenitors. 
Discussion
The role of signaling molecules in pancreatic development is best understood within the context of lineage segregation. To characterize the fate and potential of one population of b cell progenitors, we have generated a line of transgenic driver mice that expresses Cre-recombinase within the Pax4 domain of the pancreas during embryogenesis. These mice have been used in two experiments here: (1) in combination with the Z/AP reporter line to analyze the lineage of Pax4 + cells during normal development, and (2) with the Rosa Notch responder line to examine the effects of conditional Notch activation in the same cells.
The role of Pax4 in the development of endocrine subtypes
Previous studies showed that Pax4 plays a role in the development of endocrine subtypes in the islets. Pax4 expression begins in the pancreatic bud at approximately E10.5, peaks at about E15.5, and disappears shortly after birth (Sosa-Pineda et al., 1997) . Pax4 is thought to be downstream of Ngn3 in that Pax4 expression is lost in Ngn3 knockout mice (Gradwohl et al., 2000) , but Ngn3 expression is not lost in Pax4 mutants (Wang et al., 2004) . Unlike Ngn3, which is required for the differentiation of all endocrine cell types (Gradwohl et al., 2000) , Pax4 is required only for the development of b and d cells. This loss is coupled to a concomitant increase in the number of a cells (Sosa-Pineda, 2004) . Moreover, Pax4 has been shown to inhibit the expression of the homeodomain transcription factor, Arx, which has a reciprocal effect on the differentiation of endocrine fates. In the absence of Arx, a cells fail to develop and more b and d cells are observed (Collombat et al., 2003 (Collombat et al., , 2005 . One hypothesis based on these observations is that Pax4 and Arx expression in endocrine progenitors is sufficient for b/d and a cell specification, respectively. If so, one would expect that the Pax4 + population would be biased toward b/d fates and away from the a fate + population, was quantitated for 3 mice and analyzed first by ANOVA (p = 4.9 · 10 À5 ) and then by pairwise two-tailed T-tests. Statistically significant differences in labeling efficiencies are marked by different letters (e.g., a is different than b by p 6 0.05). Thus, the nEGFP label is less likely to be found in a and b cells than d and PP cells.
We tested this hypothesis via lineage tracing and observed that Pax4 + cells are not biased toward any particular endocrine fate. These data suggest that all endocrine progenitors express Pax4, and support a model whereby subtype fate is selected after Pax4 expression. This is consistent with the observation that Pax4 and Arx are co-localized in at least some endocrine progenitors (Collombat et al., 2003) . While our experiments indicate that Pax4 expression is insufficient to specify the b/d fate, they do not contradict a role for Pax4 in endocrine subtype specification. For example, it is possible that Pax4 protein levels or activity must reach a certain threshold to affect cell fate decisions. Cooperation with other subtype-specific factors may also be an important part of the specification process. Alternately, Pax4 may only be required for execution of the b/d fate once that fate has been selected by other genes. It will be informative to determine the lineage of Arx + cells and the effect of overexpressing Pax4 and Arx in different types of endocrine progenitors.
Notch shunts endocrine progenitors toward a duct fate
Notch signaling is an important regulator of pancreatic development where, as in other tissues, it has been shown to repress differentiation. When Notch-IC was expressed in mice under control of the Pdx1 promoter, which targets multiple lineages in the early pancreas, the differentiation of both endocrine and exocrine fates was suppressed. The Notch-IC + cells in these mice formed tubules that maintained expression of Pdx1 until after birth, suggesting that Notch expression in early Pdx1 + cells promotes the maintenance of undifferentiated progenitors (Murtaugh et al., 2003) . Although it is possible that some of these cells may eventually differentiate into ducts, the severity of the phenotype and the absence of exocrine tissue makes it difficult to assess duct differentiation in these mutants in a meaningful way. In the same study, Notch-IC was also shown to repress the differentiation of Ngn3 + endocrine progenitors. Unfortunately, the early demise of these embryos prevented a more complete analysis of the mature fate of Notch-IC + cells. By using the less widespread Pax4 promoter to label endocrine progenitors, we analyzed the contribution of Notch-IC + endocrine progenitors to the adult pancreas and find they incorporate into mature ducts.
It is difficult to assign a mature duct identity with 100% certainly since many markers expressed by ducts are also expressed earlier in pancreatic development by progenitor cells or later in pancreatic malignancies. However, we argue that Notch-IC shunts endocrine progenitors to a duct fate for three reasons. First, Notch-IC + cells, tracked by expression of nEGFP, often integrate smoothly into morphologically normal nEGFP À ducts in the adult pancreas. Second, many Notch + cells express a number of duct markers such as CK19, Muc1, and DBA. Finally, DBA + Notch-IC + cells fail to express markers of endocrine progenitors: Pdx1, Ngn3, Pax4, Pax6, NeuroD or Isl1or islet hormones. Taken together, these criteria indicate that the cells expressing activated Notch (Notch IC) are mature duct cells and not undifferentiated progenitors. Also, the fact that we do not observe gross abnormalities in pancreatic histology suggests that such cells are not obligated to form pancreatic tumors.
Our data emphasize that Notch activity is highly dependent on the developmental state of the responding cell and are consistent with the notion that Notch signaling may promote the duct fate during development, as originally suggested by loss-of-function studies in zebrafish (Esni et al., 2004; Lorent et al., 2004; Yee et al., 2005) . However, it has been recently reported that loss of Notch activity in the mouse pancreas by specific deletion of RBP-J K within the Pdx1 domain actually promotes the differentiation of duct-like tubules, suggesting that Notch may normally act to prevent duct differentiation (Fujikura et al., 2006) . The apparent discrepancy between gain-of-function and loss-of-function experiments in the pancreas can possibly explained if Notch signaling promotes duct differentiation passively by the fact that it prevents differentiation into endocrine or exocrine cell types. We propose that, in the short term, Notch signaling would prevent global differentiation of all cell types by causing progenitors to self-renew. Some progenitors eventually must escape this signaling and differentiate into exocrine and endocrine fates. At some point, however, the cells in the pancreatic epithelium that maintain high levels of Notch signaling would cease to be multipotent progenitors and eventually adopt a duct fate. Taken together these experiments imply that Notch signaling is neither required for duct differentiation, nor is it incompatible with duct differentiation, but promotes duct differentiation by preventing differentiation into other cell types.
The ability of Notch to control a switch between cell fates has not been observed before in the pancreas, although it is clearly and abundantly true for other tissues. Notch activity has been described as controlling the binary decision between two cell fates, such as the anchor cell vs. vulval fate in Caenorhabditis elegans or the sequential asymmetric divisions of sensory organ precursors in Drosophila (for review see (Artavanis-Tsakonas et al., 1999) . In mammals, Notch is also thought to regulate cell fate choices: neuronal vs. glial fates in the retina (Bao and Cepko, 1997) , central nervous system (Grandbarbe et al., 2003; Park and Appel, 2003) , and peripheral nervous system (Morrison et al., 2000) , epidermal vs. hair cell fates in the skin (Yamamoto et al., 2003) , and T vs. B cells in the immune system (Kawamata et al., 2002; Pui et al., 1999) , secretory vs. enterocyte fates in the intestine (Stanger et al., 2005) , and pancreatic vs. other endoderm fates in the foregut (Fukuda et al., 2006) . It is obvious in these tissues that Notch represses one primary fate, but the mechanism by which the secondary fate is selected is often less clear. In most cases, the secondary fate is thought to be the default state, and Notch has been interpreted to act permissively. However, in the case of neural crest stem cells, which are amenable to clonal analysis, Notch has been shown to have an instructive effect (Morrison et al., 2000) . Given the lack of a clonal assay in the pancreas, it is not possible to distinguish permissive, selective, or instructive effects of Notch on Pax4 + progenitors. However, if Notch-IC were acting instructively to promote the duct fate, one might expect to see precocious expression of DBA. That we do not observe such an effect at E14.5 or E16.5 (data not shown) possibly supports the idea that Notch plays a permissive role in the specification of the duct fate.
It is interesting that Pax4 + cells retain the potential to respond to Notch by becoming ducts, even though lineage tracing clearly shows they are not fated do so during normal development. This implies that during normal development Notch probably acts before the expression of Pax4 or Ngn3, and predicts the existence of Pax4 À Ngn3 À progenitors that, individually, have both endocrine and duct potential (Fig. 5, green cell, b) . Such cells may express Pdx1, but must be different than early Pdx1 + cells that respond to Notch by maintaining an undifferentiated state (Fig. 5, yellow cell, a) . We hypothesize that such endocrine/ duct progenitors disappear around E12.5, the time at which the duct lineage appears to segregate from other pancreatic lineages (Gu et al., 2002) . Furthermore, although some Pax4 + cells are multipotent and can respond to Notch-IC (Fig. 5 , purple cell, e), this competence is lost at some point during development since many of these cells are refractory to the signal and can differentiate into mature endocrine cells. This interpretation corresponds well with our observation that the endocrine progenitors most affected by Notch-IC expression are the ones that develop earliest, a and b progenitors, and that the later-developing d and PP fates are less affected. The molecular rationale for the progressive loss of responsiveness to Notch-IC in endocrine progenitors is not known. The expression of Notch signaling components in the pancreas is consistent with both their proposed role in maintenance of undifferentiated progenitors and in the promotion of the duct fate. Early in pancreatic development, Notch1, Notch2, and the ligand Dll1 are expressed broadly and diffusely in the epithelium (Apelqvist et al., 1999; Lammert et al., 2000) . However, as development proceeds expression of Notch2 becomes limited to small tubules that are reminiscent of ducts. It is unclear what causes the pancreatic epithelium to switch its developmental program from proliferation of precursors to differentiation of ducts in response to Notch. However, it appears that downregulation of Notch signaling components may be important for differentiation of the endocrine lineage since these genes tend not to be expressed in differentiated endocrine cells.
In summary, we have found that Notch signaling can specify the duct fate, one of the primary pancreatic lineages, from some pancreatic progenitors during development. These studies emphasize the importance of cell context for the interpretation of signaling pathways, an emergent theme in developmental biology with important ramifications for our ability to intervene in development and disease.
Methods
Generation of Pax4$Cre transgenic mice
The Pax4 promoter was originally intended to drive expression of a GFP-tTA fusion protein followed by an SV40 polyA termination sequence, then tetracycline operator elements (tetO-CMVmin) would drive expression of Cre-recombinase (Fig. 1A) . This pPax4-LED construct (see below) was injected into the pronucleus of B6CBA F1 zygotes, and 7 transgenic mice were generated that carried the transgene by PCR genotyping. Three of these mice transmitted the transgene to their progeny and showed Cre-mediated reporter activity when crossed to Z/AP mice. For unknown reasons we did not observe GFP expression, tTA activity, or the tetracycline-dependent inhibition of Cre expression in any of the lines. It is possible that manipulation of the original construct to remove an internal neomycin selection cassette allowed for read-through or alternate splicing. Indeed, we have used a similar construct that contains the original selection cassette to successfully express GFP-tTA and regulate expression of a different gene (unpublished data). Regardless, we generated three independent Pax4$Cre transgenic lines, all of which expressed Cre-recombinase in pancreatic progenitor cells that give rise exclusively to islets The line that drove expression in the most islet cells was selected for further studies and maintained on an ICR background.
To create the pPax4-LED construct, a tetracycline-sensitive cassette, triTAUBi (courtesy of J. Adelman, (Bond et al., 2000) was modified as follows: GFP from pGreenLantern1 (Invitrogen) and a GlyGlyAlaGlyGly linker sequence were fused to the N-terminus of tTA by recombinational PCR. The loxP-flanked selection cassette containing TK-neo and Ura3 + cells in the early pancreas (a, yellow cell) that respond to Notch by maintaining a progenitor state, some of which are probably multipotent (Gu et al., 2002; Murtaugh et al., 2003) . Additionally, lineage tracing based on the Ngn3 (Gu et al., 2002) and Pax4 promoters suggests the presence of specified progenitors (c, purple cell) that only give rise to the endocrine fate (e, red cell) during normal development. Nonetheless, our data suggest that some of these specified endocrine progenitors retain the potential to contribute to the duct fate (d, blue cell) when exposed to Notch signaling. Taken together, these data imply the existence of a transient progenitor (b, green cell) that does not express Ngn3 or Pax4 and is shunted to the duct fate by Notch signaling, rather than held in an undifferentiated state. We hypothesize that these cells express Pdx1 and that their disappearance during development corresponds to the previously observed segregation of the duct lineage at E12.5 (Gu et al., 2002) . genes was removed by digestion with Xho1/Cla1 and the vector was blunt cloned back together. Finally, nls-Cre (courtesy of G. Gu) was removed from pBluescript-KS by Xba1/Sal1 digestion and blunt cloned into the AflII site of the adapted triTAUBi vector to create pLED (lineage and expression driver). This cassette was then placed under control of the Pax4 promoter. A 4.75-kb DNA fragment from the region upstream of the Pax4 start of transcription was amplified by high fidelity PCR. (Primers: fwd, GCAATGGTACTGCCACAACGACC; rev, GAGC CTTCACTCAGGAGCAGAGGG, with Sfi1 and Spe1 restriction sites added, respectively.) This fragment was cloned into the Sfi1/Spe1 sites of pLED to generate pPax4-LED.
Animals
Z/AP mice (Lobe et al., 1999) and R26R YFP mice (Srinivas et al., 2001 ) were used as reporter lines where specified. Pax4
LacZ mice (Sosa-Pineda et al., 1997) were generously provided by B. Sosa-Pineda with permission from P. Gruss. Rosa Notch mice (Murtaugh et al., 2003) were maintained as a homozygous line. PCR genotyping was performed by standard methods.
Tissue preparation and immunostaining
In most cases (Figs. 1(B-D) , 3, and 4), embryonic and adult tissue were fixed in 4% paraformaldehyde for 30 min-2 h and processed by standard techniques to generate 15 lm cryosections for the detection of endogenous GFP signal and/or antibody staining. In a few cases (Figs. 1B and 2A-H), adult pancreata were fixed for 1-2 h in zinc formalin, wax embedded by standard techniques, sectioned (7 lm), and processed for antibody staining. Antibody staining for HPAP required antigen retrieval (Retrievagen A, BD Pharmingen), 2 min on frozen sections, 10 min on wax sections. (Tanimizu et al., 2003) , rabbit anti-Pax6 (1:1000, Chemicon), rabbit anti-Pdx1 (1:10,000, gift from C. Wright). Secondary antibodies were obtained from Jackson Immunoresearch: Rhodamine-red-X-or FITC-conjugated donkey anti-rabbit or anti-guinea pig as appropriate. Biotinylated-DBA was visualized with Alexa-647 conjugated-streptavidin (MolecularProbes) or by chromagen reaction with DAB (Vector Labs). Fluorescent images were acquired on an inverted Zeiss LSM 510 confocal microscope.
Statistical analyses
The percent contribution of hormone + cells to total islet and HPAP + populations ( Fig. 2I ) was analyzed by counting cells in 5-8 randomly selected islets per mouse from pancreatic sections stained with each hormone: glucagon, insulin, somatostatin, or PP (n = 3 mice). Islets were identified by morphology on DAPI stained sections, and each islet cell, as identified by DAPI + nuclei, was marked as expressing a hormone, HPAP, both, or neither. The percent hormone expression in the islet was compared to the percent hormone expression among HPAP + cells by a two-tailed T-test. The labeling efficiency of islet subtypes by a lineage marker (Figs. 2J and 4I) was determined by counting the percentage of hormone + cells that also expressed the lineage marker (n = 4 and 3 mice, respectively). Labeling efficiency for endocrine subtypes was first compared by single factor ANOVA, then individually by two-tailed T-test.
